Gastrointestinal Endoscopy Devices Market Size, Share & Trends Analysis | Global | 2019-2025 | 3 MedSuites | Includes: Gastrointestinal Endoscopes, Virtual Colonoscopy Software, Capsule Endoscopy, and 8 more
- Year: 2019
- Scope: 10 Years
- Region: China, Europe, United States
- Pages: 2086
- Type: MedSuite
This Global Report Series represents iData’s entire collection of country-level reports in the Gastrointestinal (GI) Endoscopy Devices Market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year:
- United States (2019)
- Europe (2019)
- China (2020)
US Gastrointestinal Endoscopy Devices Market
In 2018, the U.S. GI endoscopy device market was valued at over $2.9 billion in 2018, which is expected to exceed $3.7 billion in 2025. The main driver behind the technological advancements in the US gastrointestinal endoscopy device market is a natural preference for less and, ideally, non-invasive methods of treatment. This market steadily increases its reach into therapeutic fields addressing conditions that previously were only treatable through more invasive methods and now are treated “through-the-scope”.
The US market demand continues to be impacted by hospitals continuing to acquire outpatient facilities and expanding the reach of the group purchasing organizations (GPOs). Coupled with the reimbursement cuts across the GI space, the average selling prices are expected to remain under notable pressure, and this market study analyses the impact of this trend on the overall market.
Europe Gastrointestinal Endoscopy Devices Market
In 2018, the EU GI endoscopy devices market was valued at nearly 1.2 billion in 2019, which is expected to increase and reach just under 1.4 billion in 2025. The saturated nature of the European market will limit growth over the next 5 years. Reimbursement will continue to remain low for GI endoscopy procedures in many European countries, due to the high associated costs.
As the European population ages, incidences of colon and rectal cancer are increasing across most of the continent. Colorectal cancer is the second-leading cause of cancer deaths (after lung cancer) in the European Union. Over the past decade, media campaigns initiated by cancer awareness organizations and governmental bodies have done a lot to increase awareness of the condition and the necessity of screening for it.
China Gastrointestinal Endoscopy Devices Market
In 2019, the China GI endoscopy device market was valued at approximately $1.3 billion, with over 12.5 million colonoscopy procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 5.1% to approach $1.9 billion in 2026.
Technological advancements and product improvements over the past several years have made GI endoscopes more effective in performing GI procedures. The HD format, and now HD+ along with advanced magnification capabilities, which penetrated the Chinese market only recently, resulted in a greater detection rate for polyps. Improved designs have also made flexible GI endoscopes easier to handle, and smaller instrumentation has allowed for more specialized devices.
Global Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Procedure Volumes & Trends
- 10 Year Scope & Forecast range
- Market Drivers & Limiters for Each Market Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews & Demographic Information
- Company Profiles, Product Portfolios & SWOT for Top Competitors
Global Market Share Insights
In the US, and European gastrointestinal endoscopy markets, Boston Scientific holds the leading position. Boston Scientific has a very broad portfolio of products across the global market and is excepted to retain its leading position in the U.S. market for the foreseeable future. Boston Scientific has experienced significant growth in the biliary and pancreatic stent market since launching the AXIOS™ lumen-apposing covered-metal stent. The lumen-apposing covered-metal stent market is one the latest innovations in the ERCP space, indicated for transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts and walled-off necrosis under EUS imaging guidance.
Subsequent leading competitors vary by region, for example, Olympus holds the second-leading position in the U.S. gastrointestinal endoscopy devices market. The company’s position in the overall market is heavily weighted to its dominant position in the GI endoscope market. Olympus has been a competitor in the GI endoscopy device market since the 1950’s when they developed the Gastrocamera™. Olympus is also the leading competitor in the Chinese and Canadian markets.
Global Statistics & Procedure Trends
There are currently over 57.43 million total gastrointestinal procedures performed in the United States annually. The largest segment is GI endoscopy, which accounts for approximately 56% of the total procedure volume. The majority of these procedures are screenings related to colon cancer or the removal of abnormalities from the GI tract. On the other hand, in Europe, the total number is well over 38 million procedures, the largest segment is GI endoscopy, which accounts for approximately 46% of the total procedure volume.
According to Acid Reflux (GERD) Statistics and Facts, 60% of the adult population experience some type of GERD within a year, and up to 30% have weekly symptoms. Approximately seven million people in the US have some symptom of GERD. GERD affects 20% of Americans, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Market Segmentation Summary
While these Global Series contain all applicable market data, each of the markets are also available as stand-alone reports, MedCores. This allows you to get access to only the specific market segment research that you need.*
- Gastrointestinal Endoscopes Market | US, EU & China | MedCore
- Capsule Endoscopy Market | US, EU & China | MedCore
- Stenting and Dilation Devices Market | US, EU & China | MedCore
- Hemostasis Device Market | US, EU & China | MedCore
- Endoscopic Retrograde Cholangiopancreatography (ERCP) Market | US & EU | MedCore
- Biopsy Forceps, Polypectomy Snare & EUS Needle Market | US & EU | MedCore
- Enteral Feeding Devices Market | US & EU | MedCore
- Specimen Retrieval & Foreign-Body Removal Devices Market | US | MedCore
- Barrett’s Esophagus Ablation Device Market | US | MedCore
- Virtual Colonoscopy Market | US | MedCore
- Anti-Reflux Device Market | US | MedCore
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | United States, Europe, China |
| Base Year | 2018 – US & EU 2019 – China |
| Forecast | 2019-2025 – US & EU 2020-2026 – China |
| Historical Data | 2015-2017 – US & EU 2016-2019 – China |
| Quantitative Coverage | Market Size, Market Share, Market Growth Rates, Procedure Volumes, Units Sold, Average Selling Prices |
| Qualitative Coverage | Competitive Analysis (SWOT), Mergers & Acquisitions, Market & Procedure Growth Trends, Market Limiters, Product Portfolios, FDA Recalls, Clinical Trials, Disruptive Technologies |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data |
Top Gastrointestinal Endoscopy Companies Analyzed |
||||
|---|---|---|---|---|
|
|
|||
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET
LIST OF FIGURES XIV
LIST OF CHARTS XXXII
EXECUTIVE SUMMARY 1
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 14
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
DISEASE OVERVIEW
2.1 BASIC ANATOMY 30
2.2 DISEASE TREATMENT & DIAGNOSTICS 32
2.2.1 Gastroesophageal Reflux Disease 32
2.2.2 Barrett’s Esophagus 34
2.2.3 GI Cancer 34
2.2.4 GI bleeding 37
2.2.5 Bile Duct Diseases 38
2.2.6 Crohn’s Disease 39
2.2.7 Peptic Ulcer Disease 40
2.2.8 Intestinal Pseudo-Obstruction and Ogilvie Syndrome 40
2.3 PATIENT DEMOGRAPHICS 42
2.3.1 GI Disorders 42
2.3.1.1 General Statistics of GI Disorders for Different Years for the United States 43
2.3.1.2 Abdominal Wall Hernia 44
2.3.1.3 Chronic Constipation 45
2.3.1.4 Diverticular Disease 45
2.3.1.5 Prescriptions 45
2.3.1.6 Gastroesophageal Reflux Disease 45
2.3.1.7 Gastrointestinal Infections 46
2.3.1.8 Hemorrhoids 46
2.3.1.9 Inflammatory Bowel Disease 46
2.3.1.10 Liver Disease 47
2.3.1.11 Pancreatitis 47
2.3.1.12 Peptic Ulcer Diseases 47
2.3.2 GI Cancers 48
PRODUCT ASSESSMENT 49
3.1 INTRODUCTION 49
3.2 PRODUCT PORTFOLIOS 49
3.2.1 GI Endoscopy 49
3.2.2 Capsule Endoscopy 5
53.2.3 Virtual Colonoscopy 58
3.2.4 Stenting and Dilation Devices 60
3.2.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices 63
3.2.6 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 67
3.2.7 Foreign Body Retrieval and Specimen Removal Devices 69
3.2.8 Hemostasis Devices 713.2.9 Enteral Feeding Devices 74
3.2.10 Anti-Reflux Devices 78
3.2.11 Barrett’s Esophagus Ablation Devices 80
3.3 FDA RECALLS 823.3.1 Boston Scientific 82
3.3.1.1 ERCP 823.3.2 Cook Medical 84
3.3.2.1 Stenting and Dilation Devices 84
3.3.2.2 Biopsy Forceps, Polypectomy Snares and Fine-Needle Aspiration 85
3.3.2.3 Hemostasis Devices 853.3.3 Fujifilm 86
3.3.4 Avanos Medical 883.3.4.1 Enteral Feeding 88
3.3.5 Olympus 89
3.3.5.1 Gastrointestinal Endoscopy 89
3.3.6 Pentax Medical 91
3.3.6.1 Gastrointestinal Endoscopy 91
3.3.7 US Endoscopy 94
3.3.7.1 Foreign Body Retrieval and Specimen Removal 94
3.4 CLINICAL TRIALS 95
3.4.1 Boston Scientific 95
3.4.1.1 Stenting & Dilation 95
3.4.1.2 ERCP 98
3.4.1.3 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 108
3.4.1.4 Hemostasis Devices 112
3.4.2 Cook Medical 113
3.4.2.1 Stenting and Dilation Devices 113
3.4.2.2 ERCP 115
3.4.2.3 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 119
3.4.2.4 Hemostasis Devices 123
3.4.3 EndoGastric 125
3.4.3.1 Anti-Reflux Devices for Treatment of GERD 125
3.4.4 ERBE 128
3.4.4.1 Hemostasis Devices 128
3.4.5 Fujifilm 130
3.4.6 Medtronic 133
3.4.6.1 Capsule Endoscopy 133
3.4.6.2 Barrett’s Esophagus Ablation Devices 139
3.4.7 Olympus 143
3.4.7.1 Gastrointestinal Endoscopy 143
3.4.7.2 Capsule Endoscopy 155
3.4.7.3 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 156
3.4.7.4 Hemostasis Devices 1583.4.8 Pentax Medical 160
3.4.8.1 Gastrointestinal Endoscopy 160
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
4.1 INTRODUCTION 164
4.2 MARKET OVERVIEW 165
4.3 TREND ANALYSIS BY SEGMENT 172
4.4 DRIVERS AND LIMITERS 176
4.4.1 Market Drivers 176
4.4.2 Market Limiters 177
4.5 COMPETITIVE MARKET SHARE ANALYSIS 179
4.6 MERGERS AND ACQUISITIONS 185
4.7 COMPANY PROFILES 186
4.7.1 Boston Scientific 186
4.7.2 Cardinal Health 188
4.7.3 CONMED 190
4.7.4 Cook Medical 191
4.7.5 EndoGastric Solutions 192
4.7.6 ERBE 193
4.7.7 Fujifilm 194
4.7.8 GE Healthcare 196
4.7.9 Avanos Medical 197
4.7.10 Medline 198
4.7.11 Medtronic 200
4.7.12 Olympus 202
4.7.13 Pentax Medical 204
4.7.14 Siemens Healthineers 205
4.7.15 STERIS 206
4.7.16 US Endoscopy 207
4.7.17 Vital Images, Inc. 208
4.8 SWOT ANALYSIS 209
4.8.1 Boston Scientific 210
4.8.2 Cardinal Health 212
4.8.3 CONMED 214
4.8.4 Cook Medical 216
4.8.5 EndoGastric Solutions 218
4.8.6 ERBE 219
4.8.7 Fujifilm 220
4.8.8 GE Healthcare 223
4.8.9 Avanos Medical 225
4.8.10 Medline 227
4.8.11 Medtronic 229
4.8.12 Olympus 231
4.8.13 Pentax Medical 233
4.8.14 Siemens Healthineers 234
4.8.15 STERIS 236
4.8.16 US Endoscopy 237
4.8.17 Vital Images, Inc. 238
PROCEDURE NUMBERS 239
5.1 INTRODUCTION 239
5.2 PROCEDURES 240
5.2.1 Procedure Overview 240
5.2.2 Gastrointestinal Endoscopy Procedures 244
5.2.2.1 EGD Procedures 244
5.2.2.2 Colonoscopy Procedures 244
5.2.2.3 Sigmoidoscopy Procedures 244
5.2.2.4 Enteroscopy Procedures 244
5.2.2.5 Ultrasound Endoscopy Procedures 245
5.2.2.6 ERCP Procedures 245
5.2.3 Capsule Endoscopy Procedures 249
5.2.4 Virtual Endoscopy Procedures 251
5.2.5 Stenting Procedures 253
5.2.6 Dilation Procedures 255
5.2.7 Tissue Biopsy Procedures 257
5.2.8 Polypectomy Snare Procedures 259
5.2.9 Specimen Retrieval Procedures 261
5.2.10 Foreign-Body Removal Procedures 263
5.2.11 Hemostasis Procedures 265
5.2.12 Enteral Feeding Tube Placement Procedures 267
5.2.13 Anti-Reflux Device Implantation Procedures 269
5.2.14 Barrett’s Esophagus Ablation Procedures 271
GASTROINTESTINAL ENDOSCOPE MARKET
6.1 INTRODUCTION 273
6.2 MARKET OVERVIEW 275
6.3 MARKET ANALYSIS AND FORECAST 281
6.3.1 Total Gastrointestinal Endoscope Market 281
6.3.2 Colonoscope Market 283
6.3.3 Sigmoidoscope Market 286
6.3.4 Duodenoscope Market 288
6.3.5 Enteroscope Market 290
6.3.6 Ultrasound Endoscope Market 292
6.3.7 Double-Balloon Endoscope Market 294
6.3.8 Gastroscope Market 296
6.3.9 Third-Party Refurbished Endoscope Market 298
6.4 DRIVERS AND LIMITERS 300
6.4.1 Market Drivers 300
6.4.2 Market Limiters 301
6.5 COMPETITIVE MARKET SHARE ANALYSIS 303
6.5.1 Gastrointestinal Endoscope 303
6.5.2 Third-Party Endoscope Resale and Repair Market 307
CAPSULE ENDOSCOPY MARKET
7.1 INTRODUCTION 310
7.2 MARKET OVERVIEW 312
7.3 MARKET ANALYSIS AND FORECAST 316
7.3.1 Camera Capsule Market 316
7.3.2 Workstation Market 319
7.3.3 Data Recorder Market 321
7.4 DRIVERS AND LIMITERS 323
7.4.1 Market Drivers 323
7.4.2 Market Limiters 324
7.5 COMPETITIVE MARKET SHARE ANALYSIS 326
VIRTUAL COLONOSCOPY SOFTWARE MARKET 329
8.1 INTRODUCTION 329
8.2 MARKET ANALYSIS AND FORECAST 331
8.3 DRIVERS AND LIMITERS 334
8.3.1 Market Drivers 334
8.3.2 Market Limiters 335
8.4 COMPETITIVE MARKET SHARE ANALYSIS 337
STENTING AND DILATION DEVICE MARKET
9.1 INTRODUCTION 341
9.2 MARKET OVERVIEW 343
9.3 MARKET ANALYSIS AND FORECAST 348
9.3.1 Total Esophageal Stent Market 348
9.3.1.1 Esophageal Covered-Metal Stent Market 353
9.3.1.2 Esophageal Bare-Metal Stent Market 355
9.3.1.3 Esophageal Plastic Stent Market 357
9.3.2 Duodenal Stent Market 359
9.3.3 Colonic Stent Market 361
9.3.4 Total Esophageal Dilation Balloon Market 363
9.3.4.1 Multi-Stage Esophageal Dilation Balloon Market 367
9.3.4.2 Single-Stage Esophageal Dilation Balloon Market 369
9.3.5 Duodenal Dilation Balloon Market 371
9.3.6 Colonic Dilation Balloon Market 373
9.4 DRIVERS AND LIMITERS 375
9.4.1 Esophageal Stent Market 375
9.4.1.1 Market Drivers 375
9.4.1.2 Market Limiters 376
9.4.2 Duodenal Stent Market 377
9.4.2.1 Market Drivers 377
9.4.2.2 Market Limiters 377
9.4.3 Colonic Stent Market 378
9.4.3.1 Market Drivers 378
9.4.3.2 Market Limiters 378
9.4.4 Esophageal Dilation Balloon Market 379
9.4.4.1 Market Drivers 379
9.4.4.2 Market Limiters 379
9.4.5 Duodenal Dilation Balloon Market 381
9.4.5.1 Market Drivers 381
9.4.5.2 Market Limiters 381
9.4.6 Colonic Dilation Balloon Market 383
9.4.6.1 Market Drivers 383
9.5 COMPETITIVE MARKET SHARE ANALYSIS 384
9.5.1 Stenting and Dilation Device Market 384
9.5.2 Esophageal Stent Market 388
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET
10.1 INTRODUCTION 390
10.2 MARKET OVERVIEW 391
10.3 MARKET ANALYSIS AND FORECAST 397
10.3.1 Sphincterotome Market 397
10.3.2 Biliary Stone Removal Balloon Market 399
10.3.3 Biliary Stone Removal Basket Market 401
10.3.4 Biliary Dilation Balloon Market 403
10.3.5 Total Biliary and Pancreatic Stent Market 405
10.3.5.1 Total Biliary and Pancreatic Covered-Metal Stent Market 409
10.3.5.1.1 Biliary and Pancreatic Standard Covered-Metal Stent Market 413
10.3.5.1.2 Biliary and Pancreatic Lumen-Apposing Covered-Metal Stent Market 415
10.3.5.2 Biliary and Pancreatic Bare-Metal Stent Market 417
10.3.5.3 Biliary and Pancreatic Plastic Stent Market 419
10.3.6 Biliary Lithotripter Market 421
10.3.7 ERCP Guidewire Market 423
10.3.8 ERCP Cannula Market 425
10.4 DRIVERS AND LIMITERS 427
10.4.1 Market Drivers 427
10.4.2 Market Limiters 427
10.5 COMPETITIVE MARKET SHARE ANALYSIS 429
10.5.1 ERCP Device Market 429
10.5.2 Biliary and Pancreatic Stent Market 433
BIOPSY FORCEPS, POLYPECTOMY SNARE AND EUS NEEDLE MARKET
11.1 INTRODUCTION 435
11.2 MARKET OVERVIEW 436
11.3 MARKET ANALYSIS AND FORECAST 440
11.3.1 Total Biopsy Forceps Market 440
11.3.1.1 Cold Disposable Biopsy Forceps Market 444
11.3.1.2 Hot Disposable Biopsy Forceps Market 446
11.3.1.3 Cold Reusable Biopsy Forceps Market 448
11.3.1.4 Hot Reusable Biopsy Forceps Market 450
11.3.2 Polypectomy Snare Market 452
11.3.3 Total EUS Needle Market 454
11.3.3.1 Fine Needle Aspiration Market 458
11.3.3.2 Fine Needle Biopsy Market 460
11.4 DRIVERS AND LIMITERS 462
11.4.1 Biopsy Forceps Market 462
11.4.1.1 Market Drivers 462
11.4.1.2 Market Limiters 462
11.4.2 Polypectomy Snare Market 464
11.4.2.1 Market Drivers 464
11.4.2.2 Market Limiters 464
11.4.3 EUS Needle Market 466
11.4.3.1 Market Drivers 466
11.4.3.2 Market Limiters 466
11.5 COMPETITIVE MARKET SHARE ANALYSIS 467
11.5.1 Biopsy Forceps Market 471
11.5.2 EUS Needle Market 473
SPECIMEN RETRIEVAL AND FOREIGN-BODY REMOVAL DEVICE MARKET
12.1 INTRODUCTION 475
12.2 MARKET OVERVIEW 476
12.3 MARKET ANALYSIS AND FORECAST 480
12.3.1 Total Specimen Retrieval Device Market 480
12.3.1.1 Polyp Retrieval Trap Market 484
12.3.1.2 Specimen Retrieval Net Market 486
12.3.2 Total Foreign-Body Removal Device Market 488
12.3.2.1 Foreign-Body Removal Net Market 492
12.3.2.2 Foreign-Body Removal Grasper Market 494
12.3.2.3 Foreign-Body Removal Snare Market 496
12.4 DRIVERS AND LIMITERS 498
12.4.1 Market Drivers 498
12.4.2 Market Limiters 499
12.5 COMPETITIVE MARKET SHARE ANALYSIS 500
12.5.1 Specimen Retrieval and Foreign-Body Removal Device Market 500
12.5.2 Specimen Retrieval Device Market 503
12.5.3 Foreign-Body Removal Device Market 505
HEMOSTASIS DEVICE MARKET
13.1 INTRODUCTION 507
13.2 MARKET OVERVIEW 509
13.3 MARKET ANALYSIS AND FORECAST 514
13.3.1 Total Electrosurgical Generator Market 514
13.3.1.1 Electrosurgical Unit Market 518
13.3.1.2 Argon Module Market 521
13.3.2 Total Hemostasis Probe Market 523
13.3.2.1 Total Electrosurgical Probe Market 527
13.3.2.1.1 Conventional Electrosurgical Probe Market 531
13.3.2.1.2 Injection-Needle Probe Market 533
13.3.2.2 Heat Probe Market 535
13.3.2.3 Argon Probe Market 537
13.3.3 Total Ligation Device Market 539
13.3.3.1 Ligation Band Market 543
13.3.3.2 Ligation Clip Market 545
13.3.4 Sclerotherapy Needle Market 547
13.4 DRIVERS AND LIMITERS 549
13.4.1 Market Drivers 549
13.4.2 Market Limiters 549
13.5 COMPETITIVE MARKET SHARE ANALYSIS 551
13.5.1 Hemostasis Device Market 551
13.5.2 Electrosurgical Generator Market 555
13.5.3 Hemostasis Probe Market 557
13.5.4 Electrosurgical Probe Market 559
13.5.5 Ligation Device Market 561
ENTERAL FEEDING DEVICE MARKET
14.1 INTRODUCTION 563
14.2 MARKET OVERVIEW 564
14.3 MARKET ANALYSIS AND FORECAST 568
14.3.1 Enteral Feeding Pump Market 568
14.3.2 Total Feeding Tube Market 571
14.3.2.1 Total PEG Tube Market 576
14.3.2.1.1 Initial Placement PEG Tube Market 580
14.3.2.1.2 Total Replacement PEG Tube Market 582
14.3.2.2 DPEJ Tube Market 592
14.3.2.3 PEG-J Tube Market 594
14.3.2.4 NG/NJ Tube Market 596
14.3.3 Feeding Set Market 598
14.4 DRIVERS AND LIMITERS 600
14.4.1 Market Drivers 600
14.4.2 Market Limiters 601
14.5 COMPETITIVE MARKET SHARE ANALYSIS 602
14.5.1 Enteral Feeding Device Market 602
14.5.2 Feeding Tube Market 605
14.5.2.1 PEG Tube Market 607
ANTI-REFLUX DEVICE MARKET 609
15.1 INTRODUCTION 609
15.2 MARKET LANDSCAPE 611
15.3 MARKET ANALYSIS AND FORECAST 613
15.4 DRIVERS AND LIMITERS 616
15.4.1 Market Drivers 616
15.4.2 Market Limiters 617
15.5 COMPETITIVE MARKET SHARE ANALYSIS 618
BARRETT’S ESOPHAGUS ABLATION DEVICE MARKET
16.1 INTRODUCTION 621
16.2 MARKET OVERVIEW 622
16.3 MARKET ANALYSIS AND FORECAST 626
16.3.1 Ablation Device Market 626
16.3.2 Ablation Catheter Market 628
16.4 DRIVERS AND LIMITERS 630
16.4.1 Market Drivers 630
16.4.2 Market Limiters 630
16.5 COMPETITIVE MARKET SHARE ANALYSIS 632
ABBREVIATIONS 635
Top Gastrointestinal Endoscopy Companies Analyzed |
||||
|---|---|---|---|---|
|
|
|||
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Related Reports
